Stockpolly
Search
VBIO · NASDAQ · Biotechnology

Valion Bio (VBIO)

Develops radiation-injury immunotherapeutics and offers biologics CDMO services.

$3.04
Pre-market−0.13 (−4.04%)
At close$3.17(+3.19%)
Watchlist

In millions of USD, except per-share figures

In millionsQ2 FY24Sep 2023Q3 FY24Dec 2023Q4 FY24Mar 2024Q1 FY25Jun 2024Q2 FY25Sep 2024Q3 FY25Dec 2024Q4 FY25Mar 2025Q1 FY26Jun 2025Q2 FY26Sep 2025Q3 FY26Dec 2025Q4 FY26Mar 2026Q1 FY27Jun 2026
Revenue000000000001
Cost of revenue000000000000
Gross profit000000000000
222111122266
Research & development000000011122
221111111141
Selling & marketing011000000−100
General & administrative111110111241
Other expenses000000000003
Operating income−2−2−1−1−1−2−1−2−2−2−6−6
0000000000−1−1
Interest income000000000000
Interest expense000000000010
Other non-operating income000000000000
Income before tax−2−2−1−1−1−1−1−2−3−2−6−7
Net income from continuing operations−2−2−1−1−1−1−1−2−3−2−6−7
Discontinued operations000000000−100
Net income−2−2−1−1−1−1−2−2−3−3−6−7
EPS, basic−$25.15−$25.88−$17.15−$5.37−$3.93−$2.65−$2.64−$2.19−$1.97−$0.82−$2.23−$0.02
EPS, diluted−$25.15−$25.88−$17.15−$5.37−$3.93−$2.65−$2.52−$2.19−$1.97−$0.82−$2.23−$0.02
Weighted average shares, basic00000111133115
Weighted average shares, diluted00000111103115
EBITDA−2−2−1−1−1−1−1−2−2−2−5−6
Depreciation & amortization000000000000
EBIT−2−2−1−1−1−2−1−2−2−2−6−6